Once the trials conclude and the results are published, things could get very interesting. Personally I'm looking for $1/share + as a price target, and have little doubt that we'll get to that level. May happen with a partnership announcement in 2013, or could happen in 2014. Regardless, I'm not letting my shares go cheap...I know we have something special here and big pharma will want it.